Facebook Twitter RSS Feed

You are here


 - Radiation

WASHINGTON, D.C.—Use of a pelvic lead shield draped on a patient and a nonlead cap worn by an operator during coronary angiography reduced physician radiation exposure by more than 75 percent in a study presented Sept. 14 at the Transcatheter Cardiovascular Therapeutics scientific session.

 - PCI

For improved outcomes in patients with chronic total occlusion (CTO), intravascular ultrasound (IVUS)-guided PCI appears to win out over conventional angiography, according to results presented Sept. 14 at the Transcatheter Cardiovascular Therapeutics (TCT) conference.

 - PET/CT Scanner

PET one day may supplant invasive coronary angiography for monitoring heart transplant survivors who are at risk of developing life-threatening cardiac allograft vasculopathy, if preliminary results published online Sept. 2 hold up in larger studies. 

 - heart

Three major quantitative softwares offer cardiologists a comprehensive map of myocardial perfusion and function, but they do not always agree, according to a study in the August issue of the Journal of Nuclear Cardiology.

 - right wrong decision

Hospitals that want to reduce inappropriate PCI rates may want to look beyond the cath lab for opportunities. A study published online Aug. 25 in JAMA Internal Medicine identified diagnostic coronary angiography in asymptomatic patients as a red flag for PCI overuse.



More Stories

Cardiac PET: Quantitating myocardial blood flow with F-18 flurpiridaz

The quantitative imaging of myocardial blood flow has been gaining momentum in recent years, as is the use of F-18 flurpiridaz, which has been shown to reveal a clear demarcation of disease in patients with CAD, according to a first-in-human quantitative imaging study published July 28 in the Journal of Nuclear Medicine.

CCTA: Shedding light on appropriateness of repeat scans

Guidelines offer some direction on the appropriate use of repeated coronary CT angiography (CCTA), but how often is it actually catching anything of significance? Published July 18 in Circulation: Cardiovascular Imaging, this was the question posed by researchers hoping to guide future use.

LGE helps ID at-risk aortic valve replacement patients

The presence of late gadolinium enhancement (LGE) on cardiac MR predicted perioperative risk and worse survival in patients with severe aortic stenosis who were to undergo surgical aortic valve replacement, according to a study published in the July 15 issue of the Journal of the American College of Cardiology.

PET imaging for myocardial innervation expands with F-18 labeled agent

First-in-human study of an investigational radiotracer, F-18 LMI1195, shows clear imaging of myocardial innervation via the norepinephrine transporter system—tipping off potential adverse cardiac events, according to a study published July 3 in the Journal of Nuclear Medicine.

Gap between imaging, therapy stymies swift stroke care

In treating ischemic stroke, door-to-needle times are important for providing stroke patients with tissue plasminogen activator. However, the time between imaging the brain and initiating therapy appears to the most vulnerable to potential delays.

21% of newly diagnosed heart failure patients don’t undergo cardiovascular testing

Rates of cardiovascular testing among incident heart failure patients varied widely in a study published June 18 in the Journal of the American College of Cardiology: Cardiovascular Imaging. One-fifth of patients were not tested at all during the four months before and the six months following their hospitalization for heart failure.

Angiogenic gene therapy shows promise in phase III SPECT study

Taxus Cardium Pharmaceuticals Group have announced encouraging interim phase III cardiac SPECT imaging results from the international ASPIRE (Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease) trial. Generx Ad5FGF-4 is a potential angiogenic gene therapy for the development of new vascularization. The data was presented June 24 during the 2014 BIO International Convention in the company’s home base of San Diego.

Regadenoson safe for perfusion CMR with few adverse events

Perfusion cardiac MR (CMR) using regadenoson as an adenosine receptor was shown to be safe with few adverse events in a clinical trial published in the July issue of the European Heart Journal-Cardiovascular Imaging.

Less radiation, more monitoring

The needle recently moved in a positive direction for patients and cardiologists, or at least it showed the potential to do so, with technical and procedural advancements that may reduce radiation exposure and improve monitoring.

Next-gen scans cut radiation dose by 61% in CT angiography patients

Using advanced scanner technology reduced the radiation dose by 61 percent in patients undergoing cardiovascular CT angiography at no loss in image quality, according to a study published in the May/June issue of the Journal of Cardiovascular Computed Tomography.

Statement helps tailor care for women with suspected ischemic heart disease

Clinicians diagnosing and treating coronary heart disease in women have a new set of tools in their arsenal, thanks to gender-specific research. In a consensus statement published online June 16 in Circulation, researchers provided suggestions on how to use diagnostic testing to best review, categorize and assess disease risks in women.

Six-minute MRI may rival CT for evaluating ischemic stroke

Move over CT, MR imaging has just gotten faster. A technique developed by researchers at the University of Arizona in Tucson and the University of California, Los Angeles may help to establish MRIs as the go-to modality for evaluating acute ischemic stroke.

CCTA-guided CAD therapies help reduce LDL levels

Detection of coronary artery disease (CAD) through coronary computed tomography angiography (CCTA) may affect treatment, particularly the use of statins and aspirin, lowering cholesterol in a sustainable way and possibly improving long-term cardiovascular health.

Kids with complex heart disease at higher risk of imaging-induced cancer

While imaging technologies and medical procedures for treating cardiac conditions have improved, there are risks, particularly to the youngest patients. Researchers found that children with heart disease who have the most difficult treatment paths face the greatest long-term risks for cancer.

MPI finds more CAD five years after treatment

Stress myocardial perfusion scintigraphy (MPS) when conducted five years following percutaneous coronary intervention (PCI) has the potential to pinpoint addition disease in more than half of patients, according to a study published ahead of print May 14 in JACC: Cardiovascular Interventions.

3D CMR comparable to MPS for estimating ischemic burden

3D myocardial perfusion cardiovascular magnetic resonance MR (CMR) adds depth to looking at ischemic burden in heart patients, according to a recently published study. It one day may serve as an alternative to imaging techniques that rely on ionizing radiation.

Discovering gold in chest CTs: Incidental findings inform risk score

Physicians can use incidental findings on chest CTs to identify patients at risk of cardiovascular disease. Researchers reported online May 27 in Radiology that a validated, imaging-based risk predictor had good discriminative ability and calibration for stratifying at-risk patients.

Stress CMR predicts heart disease risk in obese patients

Stress cardiac magnetic resonance (CMR) imaging may help physicians risk stratify obese patients for cardiovascular disease, according to a study that found stress CMR to be feasible in this patient population.

ACC to imagers: Here’s a chance to get involved

As one of the largest sections in American College of Cardiology (ACC), the imaging community is expected to play a key role in its ongoing efforts to improve patient care and outcomes while lowering costs, ACC leaders wrote in the May issue of the Journal of the American College of Cardiology: Cardiovascular Imaging.

Radiotracer acts as marker, predictor in aortic stenosis

The radiotracer 18F-sodium fluoride (18F-NaF) serves as a biomarker of calcification activity in patients with aortic stenosis and may predict disease progression, according to a study published in the March issue of Circulation: Cardiovascular Imaging.